LOZAP 50mg x 30 tabl
Treatment of essential hypertension in adults and children and adolescents aged 6-18 years • Treatment of renal disease in adult patients with hypertension and type 2 diabetes mellitus with proteinuria ≥ 0.5 g/day as part of antihypertensive therapy. • Treatment of chronic heart failure in adult patients when treatment with angiotensin converting enzyme inhibitors (ACE inhibitors) is not considered appropriate due to intolerance, especially cough, or contraindication. Patients with heart failure who are stabilised on an ACE inhibitor should not be switched to losartan. Patients should have a left ventricular ejection fraction ≤ 40% and should be clinically stable and on established treatment for chronic heart failure. • Reduction of the risk of stroke in adult hypertensive patients with ECG-documented left ventricular hypertrophy (see section 5.1 LIFE study, race).Losartan potassium 50 mg
